United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 1 minute read Pharma Industry News BioMarin, DiNAQOR to develop gene therapies for rare genetic cardiomyopathies BioMarin Pharmaceutical has signed a preclinical collaboration and license deal with Swiss gene therapy platform company DiNAQOR to… bypharmanewsdailyMay 4, 2020
